← FDA DRUG APPROVALS

FDA NDA · NDA021120

NOVANTRONE

Sponsor: SERONO INC

APPLICATION
NDA021120
TYPE
NDA
ORIGINAL APPROVAL
2000-10-13
LATEST ACTION
2000-10-13
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

NOVANTRONEDiscontinued
MITOXANTRONE HYDROCHLORIDE EQ 2MG BASE/ML · INJECTABLE · INJECTION

Approval history

2000-10-13Type 6 - New Indication (no longer used) · Original · priorityLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →